Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Clinical trial NCT03452527 · TERMINATED
Trial details
- NCT number
- NCT03452527
- Sponsor
- Iconic Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2019-04-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.